ATP1A3 Acts as a Potential Anti-oncogene in Glioblastoma via the Antagonizing Interaction with Small Nuclear Ribonucleoprotein Polypeptide G
ATP1A3 is a potential anti-glioma treatment target, and its activation critically depends on its antagonizing interaction with SNRPG.
Authors
- Shuang Zou (ORCID: https://orcid.org/0000-0002-9260-4164)
- Bing Qin
- Zhiwei Shen (ORCID: https://orcid.org/0000-0003-2817-6959)
- Xiangdong Zhu (ORCID: https://orcid.org/0009-0005-2680-7093)
- Yu‐Long Lan (ORCID: https://orcid.org/0000-0003-0995-4639)
- Qichang Liu (ORCID: https://orcid.org/0009-0007-5681-4045)
- Qi Chen (ORCID: https://orcid.org/0000-0001-5971-7872)
Institutions
- Yale University (US)
- Second Affiliated Hospital of Zhejiang University (CN)
Publication Details
- Journal
- Current Neuropharmacology
- Published
- 2025-03-11
- DOI
- https://doi.org/10.2174/011570159x361656250128073206
- Citations
- 1
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.94